419 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
JAZZ Jazz Pharmaceuticals plc $161.01 $9.73B N/A
Article Searches
Jazz (JAZZ) Q2 Earnings: Will the Stock Disappoint? http://www.zacks.com/stock/news/226965/jazz-jazz-q2-earnings-will-the-stock-disappoint?cid=CS-ZC-FT-226965 Aug 05, 2016 - Our proven model does not conclusively show that Jazz (JAZZ) is likely to beat earnings estimates this quarter.
The Beautiful Relationship Between Physics and Jazz https://www.wired.com/video/physics-of-jazz May 25, 2016 - Stephon Alexander is a theoretical physicist, but he's also a jazz fanatic whose musical obsession has helped him better understand the world of cosmology, quantum gravity and particle physics.
Jazz Pharmaceuticals' (JAZZ) CEO Bruce Cozadd on Investor Update - Call Transcript http://seekingalpha.com/article/3962439-jazz-pharmaceuticals-jazz-ceo-bruce-cozadd-investor-update-call-transcript?source=feed_tag_transcripts Apr 01, 2016 - Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ) Investor Update Conference Call March 31, 2016 4:60 PM ET Executives Kathee Littrell – Vice President, Investor Relations Bruce Cozadd – Chairman and Chief Exe
Jazz: Key FDA Decision Imminent http://seekingalpha.com/article/3961293-jazz-key-fda-decision-imminent?source=feed_tag_long_ideas Mar 28, 2016 - PDUFA date of March 31 means that an FDA decision is imminent.Defibrotide should obtain FDA approval in an orphan indication for which there is a substantial unmet need.Clinical trial results and prev
Jazz Pharmaceuticals: Is Now The Time To Take Some Profits? http://seekingalpha.com/article/3522506-jazz-pharmaceuticals-is-now-the-time-to-take-some-profits?source=feed_sector_healthcare Sep 22, 2015 - Last year, there were 102 healthcare IPOs in the United States. 71 of these were biotech related, accounting for almost 25% of all IPOs in the U.S.Assuming sales growth forecasts of 15%, 7.6% and 9.1%
Should You Get Rid of Jazz Pharmaceuticals (JAZZ) Now? http://www.zacks.com/stock/news/188975/jazz-pharmaceuticals-has-been-underperforming-and-it-could-be-time-to-get-rid-of-it?cid=CS-ZC-FT-188975 Sep 04, 2015 - Jazz Pharmaceuticals has an unfavorable Zacks Rank and the stock has been witnessing a significant price decline and negative earnings estimate revisions
Alcobra, Jazz Pharmaceuticals, Nippon Telecom and Toyota Motor highlighted as Zacks Bull and Bear of the Day http://www.zacks.com/stock/news/187567/alcobra-jazz-pharmaceuticals-nippon-telecom-and-toyota-motor-highlighted-as-zacks-bull-and-bear-of-the-day?cid=CS-ZC-FT-187567 Aug 25, 2015 - Alcobra, Jazz Pharmaceuticals, Nippon Telecom and Toyota Motor highlighted as Zacks Bull and Bear of the Day
Bear of the Day: Jazz Pharma (JAZZ) http://www.zacks.com/commentary/54423/bear-of-the-day-jazz-pharma-jazz?cid=CS-ZC-FT-54423 Aug 25, 2015 - Bear of the Day: Jazz Pharma (JAZZ)
Jazz Pharmaceuticals (JAZZ) Crumbles: Stock Falls by 6.3% http://www.zacks.com/stock/news/187390/jazz-pharmaceuticals-jazz-saw-a-big-move-last-session-as-the-companys-shares-fell-by-over-6-on-the-day?cid=CS-ZC-FT-187390 Aug 24, 2015 - The slump shouldn't be too much of a surprise to investors, as Jazz Pharmaceuticals has seen 1 negative revisions in the past few weeks and its current year earnings consensus has moved lower

Pages: 1...373839404142

<<<Page 42